Implementation of a pharmacotherapy clinic into the patient centered medical home model by a second year pharmacy resident

Abstract

Patients followed in a resident run pharmacotherapy clinic in the PCMH model with interventions over six months showed significant improvements in clinical endpoints including A1c, LDL, SBP, and DBP.

Clinic-Level Population Health Intervention by PGY2 Ambulatory Care Pharmacy Residents to Optimize Medication Management in a Self-Insured Employer Health Plan Population

“…12 –15 The limited primary literature evaluating the pharmacy residents’ contribution to clinical care has demonstrated improvement in chronic disease management, identification and resolution of drug therapy problems, and improvement in 30-day readmission rates for patients with heart failure. 16 –19 When pharmacy residents are providing medication recommendations to providers, the acceptance rate has been 45% in one study 18 and 90% in another. 17 In both of these studies, the pharmacy resident was embedded in the same clinical environment as the provider.…”

Should an LDL-Cholesterol Target–Based Approach Be Readopted?

“…28 Similar successes have also been seen in private health maintenance organizations and cardiology clinics as well as in disease-specific populations such as patients with diabetes or patients undergoing hemodialysis. [29][30][31][32] The achievement of LDL goals through pharmacist-managed clinics has also been accompanied with provider and patient satisfaction as seen in a VA survey with 91.4% and 87.8% of patients and providers, respectively, reporting feeling strongly or somewhat satisfied with pharmacist-provided care. 33 Pharmacists can also help patients achieve their LDL goals through collaborative teams with physicians.…”

“…Pharmacist-managed clinics across different treatment settings and populations have been successful in increasing the number of patients reaching their LDL goals. 27-36 For example, 2 analyses of pharmacy dyslipidemia programs versus usual care in Veterans Affairs (VA) medical centers showed that significantly more patients under pharmacist care achieve their LDL goals (study 1: 64.3% vs 15.7%, P < 0.001; study 2: 80.3% vs 65.3%, adjusted odds ratio = 2.6, 95% confidence interval [CI] = 1.6-4.3). 27,28 Furthermore, the time to achieve LDL goal is significantly shorter in pharmacist-managed clinics (risk ratio = 1.8, 95% CI = 1.2-2.8).…”

Impact of an Advanced Practice Pharmacist Type 2 Diabetes Management Program: A Pilot Study

“…12 Many studies concluded that a pharmacist's involvement positively affects diabetes management and could reduce cost. [12][13][14][15][16][17][18][19][20][21][22][23][24] In the state of California, pharmacists can hold the special designation of Advanced Practice Pharmacist (APh) if they satisfy certain criteria. The APh is authorized to perform patient assessments, refer patients to other health care providers and initiate, adjust, and discontinue drug therapy.…”